Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Prices For Medicare, Non-Medicare Groups Show Similar Growth – GAO

Executive Summary

Retail prices for drugs frequently used by Medicare enrollees are increasing at a "similar" rate to those used by the non-Medicare population, the Government Accountability Office said

You may also be interested in...



GAO Drug Price Study Finds Fraction Of Products Accounts For Most Increases

A Government Accountability Office study of drug prices found that a limited number of drugs were responsible for the vast majority of drug price increases between 2000 and 2004

GAO Drug Price Study Finds Fraction Of Products Accounts For Most Increases

A Government Accountability Office study of drug prices found that a limited number of drugs were responsible for the vast majority of drug price increases between 2000 and 2004

PhRMA Studies Contest AARP Drug Price “Watchdog Report”

Prescription drug prices rose only 0.9% in the first quarter of 2004, not 3.4% as AARP claims, a study of Bureau of Labor Statistics data commissioned by the Pharmaceutical Research & Manufacturers of America says

UsernamePublicRestriction

Register

ID1132090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel